Stock listing

Shanghai:688443 Chongqing Genrix Biopharmaceutical Co., Ltd. (智翔金泰) 股价

Follow Chongqing Genrix Biopharmaceutical Co., Ltd. into a list and get an email when it puts out news.

Share price · SSE:688443

¥25.32 CNY -0.52 (-2.0%)

Close on Nov 3, 2026

Past year -17.1% · daily closes, Nov 3, 2025 – Nov 3, 2026, adjusted for splits
Day range
¥24.90 – ¥25.81 CNYNov 3, 2026
Volume
6.75M sharesNov 3, 2026
Market cap
¥9.28B CNYAt the close on Nov 3, 2026 · price × 366.7M shares outstanding
52-week range
¥20.07 – ¥32.82 CNYLowest and highest trades, Nov 4, 2025 – Nov 3, 2026
Traded on an average day
¥90.96M CNYMedian day 3.24M shares · last 3 months, Aug 3, 2026 – Nov 3, 2026
Chongqing Genrix Biopharmaceutical Co., Ltd. logo

Daily closes

Last 3 months, Aug 3, 2026 – Nov 3, 2026 · SSE:688443 · CNY, adjusted for splits

DayCloseChange%OpenHighLowVolume
¥25.32-0.52-2.0%¥25.67¥25.81¥24.906,754,370
¥25.84+2.71+11.7%¥24.80¥26.08¥24.2611,870,198
¥23.13+0.27+1.2%¥22.95¥24.36¥22.413,242,754
¥22.86-0.46-2.0%¥23.33¥23.38¥22.712,082,230
¥23.32+0.52+2.3%¥23.15¥23.68¥22.612,217,739
¥22.80-1.40-5.8%¥24.47¥24.52¥22.802,678,879
¥24.20+0.09+0.4%¥24.17¥24.57¥23.552,656,344
¥24.11+1.23+5.4%¥22.71¥24.29¥22.203,224,981
¥22.88-0.51-2.2%¥23.49¥23.98¥22.741,888,178
¥23.39-0.11-0.5%¥23.78¥24.15¥23.351,691,851
¥23.50+0.42+1.8%¥23.58¥23.62¥22.482,386,200
¥23.08+0.08+0.3%¥22.80¥23.58¥22.662,648,665
¥23.00+0.22+1.0%¥23.02¥23.72¥22.682,554,284
¥22.78-0.41-1.8%¥23.32¥23.49¥22.652,553,593
¥23.19-1.01-4.2%¥24.21¥24.22¥23.142,389,347
¥24.20-0.81-3.2%¥24.82¥24.96¥23.852,313,073
¥25.01+0.06+0.2%¥25.03¥25.88¥24.762,818,431
¥24.95-0.60-2.3%¥25.37¥25.58¥24.513,462,621
¥25.55+0.25+1.0%¥25.44¥25.63¥24.666,075,469
¥25.30+1.16+4.8%¥24.29¥25.62¥24.145,602,509
¥24.14-0.10-0.4%¥24.25¥24.87¥23.922,648,872
¥24.24-0.37-1.5%¥24.73¥24.89¥24.003,401,926
¥24.61-0.88-3.5%¥25.36¥25.64¥24.574,410,041
¥25.49+0.30+1.2%¥25.10¥25.93¥25.004,340,379
¥25.19+0.68+2.8%¥24.57¥25.25¥24.335,515,841
¥24.51+1.61+7.0%¥23.13¥24.58¥23.055,261,782
¥22.90+0.44+2.0%¥22.57¥23.41¥22.572,562,933
¥22.46+0.16+0.7%¥22.28¥22.58¥22.231,964,238
¥22.30+0.11+0.5%¥22.16¥22.40¥21.921,728,917
¥22.19-0.26-1.2%¥22.53¥22.53¥22.061,206,187
¥22.45+0.56+2.6%¥21.89¥22.53¥21.661,711,462
¥21.89-0.48-2.1%¥22.49¥22.49¥21.641,916,203
¥22.37-0.20-0.9%¥22.46¥22.62¥21.922,805,917
¥22.57-0.46-2.0%¥22.91¥23.09¥22.572,022,972
¥23.03+0.06+0.3%¥22.98¥23.24¥22.662,007,737
¥22.97-0.28-1.2%¥23.26¥23.28¥22.962,409,701
¥23.25-0.29-1.2%¥23.61¥23.80¥23.152,865,743
¥23.54+0.45+1.9%¥23.05¥23.76¥22.943,162,510
¥23.09+0.09+0.4%¥23.00¥23.41¥22.643,111,393
¥23.00-0.68-2.9%¥23.60¥23.67¥22.934,713,370
¥23.68-0.54-2.2%¥23.88¥24.60¥23.583,531,476
¥24.22-0.58-2.3%¥25.72¥26.50¥24.135,195,184
¥24.80+0.08+0.3%¥24.74¥24.93¥24.113,568,437
¥24.72+0.04+0.2%¥24.64¥25.65¥24.403,095,027
¥24.68+0.08+0.3%¥24.44¥24.86¥24.004,010,837
¥24.60-1.35-5.2%¥25.83¥26.35¥24.444,388,627
¥25.95-0.83-3.1%¥26.28¥26.75¥25.774,616,382
¥26.78+0.90+3.5%¥26.96¥27.70¥26.366,587,830
¥25.88-0.56-2.1%¥26.31¥26.77¥25.574,333,727
¥26.44+0.29+1.1%¥26.45¥27.15¥26.205,009,505
¥26.15-0.21-0.8%¥26.16¥26.59¥25.742,835,684
¥26.36-0.40-1.5%¥26.80¥27.07¥26.033,761,217
¥26.76+0.73+2.8%¥26.16¥27.70¥25.675,674,568
¥26.03-0.30-1.1%¥26.25¥27.05¥25.814,497,559
¥26.33+1.54+6.2%¥24.60¥27.24¥24.507,748,169
¥24.79+0.15+0.6%¥24.83¥25.53¥24.444,989,200
¥24.64+1.70+7.4%¥22.73¥24.75¥22.736,517,180
¥22.94-0.48-2.0%¥23.31¥23.52¥22.783,649,239
¥23.42+0.27+1.2%¥22.81¥23.89¥22.813,379,357
¥23.15+0.52+2.3%¥22.83¥23.37¥22.694,165,735
¥22.63+0.41+1.8%¥22.24¥23.10¥22.103,808,307
Ticker
Shanghai:688443
Asset type
Stock
Exchange
Shanghai
Currency
CNY

What changed lately

Latest news

(688443)"CHONGQING GENRIX BIOPHARMACEUTICAL CO., LTD."Announcement on Voluntary Disclosure of Inclusion of Telikibart Injection in the Priority Review Drug List

Nov 4, 2026

(688443)"CHONGQING GENRIX BIOPHARMACEUTICAL CO., LTD."Announcement on Voluntary Disclosure of the Acceptance of the Marketing Application for Telikibart Injection for the Indication of Chronic Spontaneous Urticaria

Oct 24, 2026

Closed ¥24.20 (+0.4%) on Oct 26, 2026

(688443)"CHONGQING GENRIX BIOPHARMACEUTICAL CO., LTD."Announcement on Voluntary Disclosure of the Acceptance of the New Drug Application for Telikibart Injection for the Indication of Chronic Rhinosinusitis with Nasal Polyps

Oct 15, 2026

Closed ¥22.78 (-1.8%) on Oct 15, 2026

(688443)"CHONGQING GENRIX BIOPHARMACEUTICAL CO., LTD."Announcement on Change of Signing Certified Public Accountant

Oct 10, 2026

Closed ¥25.01 (+0.2%) on Oct 12, 2026

Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Chongqing Jurisdiction and Semi-annual Performance Briefing

Sep 16, 2026

Closed ¥22.30 (+0.5%) on Sep 16, 2026

Announcement on Convening the 2026 Semi-annual Performance Briefing

Sep 8, 2026

Closed ¥23.03 (+0.3%) on Sep 8, 2026

Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026

Aug 31, 2026

Closed ¥23.68 (-2.2%) on Aug 31, 2026

Announcement on Voluntary Disclosure of the Conditional Approval for Marketing of Velinotamig Injection

Aug 28, 2026

Closed ¥24.22 (-2.3%) on Aug 28, 2026

Announcement on Voluntary Disclosure of Obtaining the Notice of Approval for Clinical Trial of GR2302 Injection for the Indication of Chronic Hepatitis B

Aug 19, 2026

Closed ¥25.88 (-2.1%) on Aug 19, 2026

Announcement on Voluntary Disclosure of Obtaining the Notice of Approval for Clinical Trial of GR2302 Injection

Aug 18, 2026

Closed ¥26.44 (+1.1%) on Aug 18, 2026

All Chongqing Genrix Biopharmaceutical Co., Ltd. news

Chongqing Genrix Biopharmaceutical Co., Ltd. on 6ix

News releases
33 in the last 12 months · 60 in all · newest Nov 4, 2026 · oldest 2024

Log in to ask 6ix AI your own questions about Chongqing Genrix Biopharmaceutical Co., Ltd.